Pregnancy and Breastfeeding: The safety of Semaglutide during pregnancy and breastfeeding is not well-established
More serious but rare side effects include increased blood pressure, heart palpitations, dizziness, restlessness, tremors, insomnia, shortness of breath, chest pain, severe skin reactions, and swelling in the legs and ankles
Synergy with GLP-1 Therapies Enhanced results when combined with semaglutide: Studies suggest that Cagrilintide + GLP-1 therapy produces greater weight loss than either drug alone
Census Bureau and the Chicago Health and Aging Project (CHAP), a populationbased study of chronic health conditions of older people
In kidney aging studies, it protected renal tubular epithelial cells, reduced renal inflammation, and improved renal function
Epithalon is generally well-suited for patients 35+ focusing on aging modulation, though younger patients may benefit in specific contexts